# Evaluating Pediatric Ivermectin in Children Under 15 kg (EPIC-15)

> **NCT06404333** · PHASE2 · COMPLETED · sponsor: **University of Oxford** · enrollment: 13 (actual)

## Conditions studied

- Scabies

## Interventions

- **DRUG:** CHILD-IVITAB
- **DRUG:** CHILD-IVITAB

## Key facts

- **NCT ID:** NCT06404333
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-25
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06404333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06404333, "Evaluating Pediatric Ivermectin in Children Under 15 kg (EPIC-15)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06404333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*